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Summary and clinical implications
This thesis addresses diverse aspects of dai ly cl in ical  pract ice in a sett ing where al l
patients presenting with acute myocardial infarction are treated with primary
angioplasty.  The importance of pre-hospital  infarct ion-diagnosis and tr iage, the in-
f luence of pharmacological  pre-treatment before pr imary angioplasty,  the extent of
platelet aggregat ion inhibi t ion with di f ferent ant iplatelet t reatment regimens, the
importance of in i t ia l  patency of the infarct-related artery and outcome after fai lure
of mechanical reperfusion therapy are analysed.
Chapter 1 starts with an introduction and overview of this thesis.
In chapter 2 we evaluate, in the PHIAT (Pre-Hospital Infarction Angioplasty Triage)
project,  safety and feasibi l i ty of  in-ambulance electrocardiography faci l i t ies for pre-
hospital  t r iage and direct ransfer to an intervent ional centre to undergo immediate
coronary angiography and angiography-guided therapy. The ambulances were
equipped with a def ibr i l lator and electrocardiography unit  with computer ised
electrocardiographic analysis. Patients with acute myocardial infarction symptoms
and ful f i l l ing certain cr i ter ia compatible with a large myocardial  infarct ion were
included. During the study period, 284 pat ients met the PHIAT cr i ter ia.  Eleven
percent of the ident i f ied pat ients did not have an acute myocardial  infarct ion.
Primary angioplasty was successful  in 94o/o. Pre-hospital  t r iage reduced t ime to
treatment; in 32o/s of the patients triage resulted in direct transportation to the
intervent ional centre instead of t ransportat ion via the nearest community hospital .
Pre-hospital  t r iage in the ambulance is a safe and feasible way to ident i fy pat ients
with acute myocardial  infarct ion in order to transport  them direct ly to an
intervent ional centre. Al l  ef forts should be made to implement pre-hospital
infarct ion diagnosis and tr iage in the ambulance service structure. So far,  many
regions in the Netherlands have adopted this "Zwol le" concept.
In chapter 3 we give an overview oÍ different possibilities of pre-procedural
pharmacological  therapy for pat ients with acute myocardial  infarct ion treated with
pr imary angioplasty.  With the increasing use of pr imary angioplasty,  more pat ients
wi l l  be transferred to an intervent ional centre. As the importance of an open
infarct-related artery at acute angiography becomes clear, pharmacological pre-
treatment with a glycoprotein llb/ll la receptor blocker, on top of administration oÍ
aspir in and heparin,  with the aim to open the infarct-related vessel dur ing
transportation seems to be the treatment of choice, especially because of its relative
safety.
In chapter 4 we describe the inf  luence of pre-hospital  dministrat ion of aspir in and
heparin on initial patency of the infarct-related artery in patients with acute myo-
cardial  infarct ion treated with pr imary angioplasty.  Angiographic data and 30-day
clinical outcome oÍ 17O2 acute myocardial infarction patients treated with primary
angioplasty were studied; 860 pat ients received aspir in and heparin before
transportation to our hospital and 842 patients received these agents in our
hospital .  The Thrombolysis In Myocardial  Infarct ion (TlMl) 2 or 3 f low in the infarct-
related artery was higher in the group treated with aspir in and heparin in the pre-
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hospital  phase (317o versus 20%, RR 0.65 [95%Cl 0.55-0.78],  p<0.001).  Pat ients with
TlMl 2 or 3 flow on the initial angiogram had a higher angioplasty success rate (94o/o
versus 89%, p<0.001),  a smal ler enzymatic infarct s ize, a higher lef t  ventr icular
eject ion fract ion and a lower 30-day mortal i ty (1.6% versus 3.4o/o, p=0.04).  Al l
patients with acute myocardial infarction, transported to an interventional centre
to undergo pr imary angioplasty,  should be treated with aspir in and heparin in the
pre-hospital phase, before admission to the interventional centre.
In chapter 5 we discuss the results of the Ongoing Tirof iban ln Myocardial  infarct ion
Evaluat ion (On-TIME) tr ia l .  ln this tr ia l ,  507 pat ients with acute myocardial
infarction, who were transferred to undergo primary angioplasty, were randomised
to early,  pre-hospital  in i t iat ion of Tirof iban (Early) or to ini t iat ion of Tirof iban in the
catheterisation laboratory (Late). A large proportion of patients (41%) was
diagnosed and randomised in the ambulance. without intervent ion of a physician.
ln the Early group, Tirof iban was administered a median of 59 minutes (range 11-
178) earl ier than in the Late group. At in i t ia l  angiography, TlMl 3 f low was present
in 19% in the Early group and in 15% in the Late group (p=0.22).  Thrombus or fresh
occlusion was present in 60% in the Early and 73o/o in the Late group (p=0.002). A
pre-procedural  myocardial  blush grade 2 or 3 was more often present in the Early
group (30% versus 22o/o, p=Q.Q{).  No di f ference in TlMl 3 f low or myocardial  blush
grade was found between the groups after primary angioplasty. At one-year follow-
up, the combined incidence of death or recurrent myocardial  infarct ion was not
dífferent between the groups (7.0% versus 7.0%, p=0.99). As this study excluded
very high-r isk pat ients,  future studies on faci l i tat ion of pr imary angioplasty should
focus on the high-r isk populat ion, which may specif ical ly benef i t  f rom an open
i nf a rct-related vesse I before pri mary ang ioplasty.
In chapter 6 we report a quantitative analysis of the benefits of pre-hospital
infarction angioplasty triage on outcome in patients undergoing primary angioplasty
for acute myocardial infarction. ln this study, pre-hospital infarction-diagnosis and
triage in the ambulance (n=209) were compared with triage at a referral centre
without faci l i t ies for pr imary angioplasty (n=258) in pat ients included in the On-TIME
(Ongoing Tirof iban In Myocardial  infarct ion Evaluat ion) tr ia l .  Basel ine character ist ics
were not different, apart from a higher prevalence of male gender in patients
recrui ted in the ambulance. The ambulance group had a signi f icant ly shorter t ime to
treatment (177 versus 208 minutes, p<0.001), a higher initial patency rate (combined
TlMf 2 or 3 flow 44o/o versus 35%, p=0.0+5), a better extent of myocardial reperfusion
(Myocardial Blush Grade 3; 59Vo versus 47oÁ, p=0.02; complete ST-segment
resolution: 78% versus 67o/o, p=Q.Q)), a trend towards a higher prevalence of aborted
myocardial  infarct ion (15% versus 10%, p=Q.Q3) and a signi f icant ly lower rate of
death or recurrent myocardial infarction at 1-year follow-up (3% versus 10%,
p=0.004). The results of this study also confirm the importance of pre-hospital
infarction diagnosis and triage in the ambulance, in order to transport patients with
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In chapter  7 we evaluate the extent  of  achieved p late let  aggregat ion inhib i t ion in
pat ients wi th acute myocardia l  in farct ion undergoing pr imary angioplasty and
treated with different antiplatelet agents and dosages. Patients were treated with
Clopidogrel  before angiography and randomised to Abcix imab,  T i rof iban,  h igh-
dose Tirofiban, or no glycoprotein l lb/l l la inhibitor. In case the patient was
randomised to treatment with a glycoprotein l lb/l l la inhibitoÍ; the bolus, immediately
followed by maintenance infusion, was administered after angiography, but beÍore
pr imary angíoplasty in  a l l  pat ients.  Plate let  aggregat ion inhib i t ion was assessed
before angiography,  immediate ly  af ter  pr imary angioplasty,  and 1 and 6 hours
afterwards. The total study population consisted of 112 patients. Platelet
aggregat ion inhib i t ion was var iable for  ind iv iduals and sub-opt imal  for  a l l  agents,
par t icu lar ly  in  the per iprocedural  per iod.  Only wi th h igh-dose Ti rof iban,  mean per i -
procedural  p late let  aggregat ion inhib i t ion exceeded 80%. Angiographic
parameters after primary angioplasty were not different between the groups. No
relat ionship was íound between the level  of  p late let  aggregat ion and parameters
of primary angioplasty success (Thrombolysis In Myocardial Infarction frame count
and myocardia l  b lush grade),  af ter  combin ing the data f rom al l  four  groups studied.
Larger studies should be performed to assess whether dose adjustment or
combinat ion therapy of  d i f ferent  ant ip late let  agents can fur ther  improve p late let
aggregat ion inhib i t ion and c l in ica l  outcome.
In chapter 8 we focus on the impact of patency of the infarct-related artery on the
coronary angiogram, both beÍore and af ter  pr imary angioplasty for  acute
myocardial infarction, on 30-day mortality. In a descriptive cohort study, data of
1702 consecutive patients treated with primary angioplasty for acute myocardial
infarction were collected prospectively. Patients with a (partially) patent infarct-
re lated ar tery (T lMl f low grade2 or  3)  before pr imary angioplasty had less damage
to the myocardium and a lower 30-day morta l i ty  (1.6% versus 3.4o/o,  p=0.04)
compared wi th pat ients wi th an occluded ar tery.  Pat ients wi th pre-hospi ta l
t reatment  wi th aspi r in  and hepar in more of ten presented wi th a (par t ia l ly)  patent
(TlMl f low grade 2 or 3) artery before angioplasty (31% versus 20%, p<0.001). After
primary angioplasty, 95o/o oÍ patients had a patent artery with a 30-day mortality of
2.2%.The 5o/o f  pat ients wi th fa i led angioplasty had extensive myocardia l  damage
and a 30-day mortality rate of 17%. All efforts should be made to obtain early and
optimal restoration of antegrade flow of the infarct-related artery as early as
possib le,  especia l ly  when t ransportat ion to in tervent ional  centres,  wi th conceivably
fur ther  t ime-delay,  is  requi red.
In chapter  9 we repor t  the impact  of  any increase in in i t ia l  patency of  the in farct -
related artery on outcome in patients with acute myocardial infarction treated with
pr imary angioplasty.  We studied c l in ica l  and angiographic data of  1702 pat ients
with acute myocardial infarction treated with primary angioplasty. In 1683 patients
(98.9%) in i t ia l  patency could be assessed.  T lMl  0 f low was present  in  650/o,  T lMl  1
f low in 10%, TlMl  2 Í low in 12o/o and TlMl  3 f low in 13oÁ. Pr imary angioplasty was
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successfu l  in  94.70Á. Al l  outcome measures showed improved outcome wi th
increasing TlMl  f low:  increased success oÍ  pr imary angioplasty (p for  t rend < 0.00 ' l ) ,
increased inc idence of  myocardia l  b lush grade 2/3 and 3 a lone (p for  t rend < 0.001;
p for  t rend < 0.001,  respect ive ly) ,  decreased enzymat ic  in farct  s ize (p for  t rend
< 0.001),  increased lef t  ventr icu lar  e ject ion f ract ion (p for  t rend < 0.001),  and
decreased 30-day and 1-year mortality (p for trend = 0.0'19; p for trend = 0.008,
respectively).
In  chapter ' l  0  we descr ibe the impact  of  fa i led mechanical  reper fus ion in  pat ients
wíth acute myocardial infarction treated with primary angioplasty. ln the study
populat ion of  1568 pat ients,  reper fus ion was successfu l  in  93.1% and fa i led
reperfus ion occurred in  6.9o/o.  Ki l l ip  c lass > 1 at  admiss ion (OR 5.7,95o/oCl  3.1-10.4,
p<0.001),  a le f t  anter ior  descending ar tery as the in farct - re lated ar tery (OR 2.0,
95%Cl:  1.2-3.4,  P=0.01)  or  a pre-procedural  T lMl  0 or  T lMl  1 f low (OR 4.7,  95oÁCl:2.0-
1 1.1,  p<0.001),  were independent  predictors of  fa i led reper fus ion.  Pat ients in  whom
reperfusion was not successful had a significantly lower left ventricular ejection
fract ion compared to pat ients wi th successfu l  reper fus ion (39.9 + 11.9 versus 43.6t
' l1 .2,  p-0.007).  In-hospi ta l  morta l i ty  was 160/o versus 2% (p<0.001),  30-day morta l i ty
2 ' f  %o versus 3 % (p<0.001),  and 1-year  morta l i ty  27Yo versus 5% (p<0.001) in  pat ients
wi th Ía i led versus successfu l  reper Íus ion.  Wi th in the group of  pat ients wi th fa i led
reperfusion, primary angioplasty was not successful in 52o/o and in 48o/o a late re-
occlus ion occurred dur ing hospi ta l  s tay.  Lef t  ventr icu lar  e ject ion f ract ion d id not
d i f fer  s igni f icant ly  between pat ients in  whom pr imary angioplasty was not
successful versus patients who suffered from late re-occlusion (39.0 + 12.6 versus
40.5 + 11.5,  p=0.60) .  Pat ients in  whom pr imary angioplasty was not  successfu l  had
the h ighest  in i t ia l  ( in-hospi ta l )  morta l i ty  rate and th is  t rend remained stable dur ing
fo l low-up.
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